Huahai Pharmaceutical: "Huahai convertible bonds" may trigger price adjustment

Zhejiang Huahai Pharmaceutical (SSE:600521) announced that its "Huahai Convertible Bonds" (SSE:110076) are likely to trigger a downward adjustment of the conversion price. The announcement, released on April 18, 2025, notes that for 10 trading days between April 4, 2025, and April 18, 2025, the company's stock closing price has been below 80% of the current conversion price of CNY 33.21 per share. The company plans to convene a board meeting to decide whether to adjust the conversion price, as stipulated by regulations governing convertible bonds on the Shanghai Stock Exchange. The initial offering of these bonds totaled CNY 1,842,600,000.00. The bonds were listed on the Shanghai Stock Exchange on November 25, 2020.